Immune Responses to Yellow Fever Vaccine
Turnover of Antigen Specific Lymphocytes After Immunization With the Yellow Fever Vaccine
Human Immune Responses to The Yellow Fever Virus Vaccine
A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
Yellow Fever Vaccination Under Low Dose Methotrexate Therapy
|7||Not yet recruiting||
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
† Study has passed its completion date and status has not been verified in more than two years.